Phase III trial of everolimus in metastatic renal cell carcinoma: Subgroup ... - UroToday PDF Print
UroToday

To assess the efficacy and safety of everolimus in Japanese patients with metastatic renal cell carcinoma. A subgroup analysis of the pivotal Phase III,

... phase iii trial of everolimus in metastatic renal cell carcinoma subgroup analysis of japanese patients from record1 abstract

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.

Notice: Undefined variable: query in /home/globaldi/public_html/components/com_joomlawatch/class.joomlawatch.db.php on line 129